ArticleThe American journal of case reports2026
Histologically Confirmed Brain Metastasis Arising From Giant Cell Tumor of Bone: an Uncommon Entity and a Challenging Condition.
Article in The American journal of case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND Giant cell tumors of bone (GCTBs), while classified as indolent, are characterized by their locally aggressive nature and their ability to form metastases in rare cases, mainly in the lungs. To our knowledge, this case is the third reported case of GCTB central nervous system involvement in the literature. CASE REPORT We report the exceptional case of a 39-year-old patient with no significant medical history who presented with a GCTB of the left distal femur, treated with preoperative denosumab and surgical resection with massive prosthetic reconstruction. Fifteen months later, the onset of tremors and a partial seizure revealed a right parietal brain metastasis, histologically confirmed as a secondary site of GCTB. Management included surgical excision of the brain lesion, followed by close monitoring with brain MRI, without adjuvant radiotherapy. Before the present report, only 2 cases of GCTB metastasis involving the central nervous system have been reported, including an intramedullary thoracic lesion and bilateral parietal lesions. CONCLUSIONS This case is the third reported case of GCTB metastasis with central nervous system involvement, highlighting the importance of prolonged follow-up and an individualized multidisciplinary approach for these tumors, which usually metastasize to the lungs. Although these 3 case reports help to characterize this rare condition of secondary central nervous system involvement in GCTBs, they do not justify routine brain imaging or a set standard for follow-up strategies; instead, a multidisciplinary and individualized approach is recommended. The patient is currently in clinical and radiological remission.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.